Viromed Medical AG
Research Viromed Medical AG (Q11) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerQ11
- ExchangeHM
- CurrencyEUR
- Financial periodQ3 2025
- RevenueCAD 12.84M
- Net income-CAD 5.31M
- Free cash flow-CAD 30.34M
- Gross margin46.2%